Envudeucitinib, a tyrosine kinase 2 (TYK2) inhibitor, demonstrated rapid improvement and progressively deepening skin ...
No amount of any food will make psoriasis disappear. But what you put on your plate can help. Experts share the best diet to ...
Unbearably itchy skin, angry red patches and a huge dent to self-confidence are just some of the symptoms of psoriasis - a ...
Alumis Inc. recently reported past Phase 3 ONWARD1 and ONWARD2 trial results showing envudeucitinib, its oral TYK2 inhibitor, delivered high skin clearance, rapid itch relief, and quality-of-life ...
Get all latest & breaking news on Hair Loss. Watch videos, top stories and articles on Hair Loss at moneycontrol.com.
Not washing your hair for extended periods can lead to short and long-term effects like scalp buildup, odor, and increased ...
Envudeucitinib, another allosteric TYK2 inhibitor, also achieved PASI 75 in 70-75% of patients at 16 weeks and PGA 0/1 status ...
Deucravacitinib showed strong psoriasis control and rapid scalp clearance with mild adverse events in real-world practice.
Psoriasis is a long-term skin condition that affects millions of people around the world. It causes red, dry, and scaly ...
A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...
One-year Phase 3 data for ICOTYDE to be presented at AAD 2026 demonstrate lasting skin clearance and a favorable safety ...
Alumis Inc. ALMS shares tumbled Monday despite strong clinical trial outcomes, as investors locked in gains following a 239% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results